A multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Centre investigated the efficacy of combining an immunomodulatory...
cancer progression
Browsing
By navigating our site, you agree to allow us to use cookies, in accordance with our Privacy Policy.